NCT00097617

A Study in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (ESRD)

National Cooperative Growth Study (NCGS) of Nutropin AQ, Nutropin, and Protropin in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (ESRD)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 395 (actual)
• Sponsor: Genentech, Inc. · Industry
• Sex: All
• Age: 17 Years
• Healthy volunteers: Not accepted

Summary

This study is a multicenter, open-label, observational, postmarketing surveillance study that will collect information on the use of Genentech growth hormone (GH) preparations to treat children with CRI in the United States.

Conditions

• Chronic Renal Insufficiency
• End-Stage Renal Disease

Timeline

• Start date: 2002-03-01
• Primary completion: 2010-07-01
• Completion: 2010-07-01
• First posted: 2004-11-25
• Last updated: 2012-11-14